ContractClinical Trial Agreement • September 16th, 2022
Contract Type FiledSeptember 16th, 2022Clinical Trial Agreement F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland; VAT no.: CHE- 116.267.986 MWST(Hereinafter referred to as the ‘Sponsor’) andIQVIA RDS Czech Republic s.r.oPernerova 691/42186 00 Praha 8, The Czech RepublicID no: 24768651Tax Identification no: CZ24768651 Czech Republic, represented by Ing. Eva Falbrová,Managing Director(Hereinafter referred to as the ‘IQVIA’) andFakultní nemocnice u sv. Anny v Brně, having a place of business at Pekařská 664/53, 602 00 Brno, Czech Republic, Identification number: 00159816, Tax identification number: CZ00159816, represented by Ing. Vlastimil Vajdák,Director(Hereinafter referred to as the ‘Institution’) and Address: , CzechRepublic Date of birth:(Hereinafter referred to as the “Principal Investigator”) Preamble: The Sponsor shall be deemed within the meaning of the Act on Drugs No. 378/2007 Coll., as amended. Smlouva o klinickém hodnocení F. Hoffmann-La Roche Ltd, se sídlem